EGFR and glioblastoma: These findings identify an axis in which TMZ induces ADAM8 and leads to downstream signaling that causes the enhanced secretion of CCL2 to recruit TAMs into GBM under TMZ treatment via the HB-EGF/EGFR signaling pathway.